lorlatinib 25 MG Oral Tablet

RxCUI
2103169
RxNorm name
lorlatinib 25 MG Oral Tablet
Display name
lorlatinib 25 MG Oral Tablet
Full name
lorlatinib 25 MG Oral Tablet
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:51

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
LorbrenaLORLATINIBPfizer Laboratories Div Pfizer Inc2b34d62d-e02a-4af3-bc0d-1571dd4ee76d2026-06-26Warnings, Adverse reactionsExact identifier
rxcui: 2103169
LorbrenaLORLATINIBU.S. Pharmaceuticals004f93d7-a1cd-4b67-9207-31cdcb5c59762026-02-13Warnings, Adverse reactionsExact identifier
rxcui: 2103169

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
2b34d62d-e02a-4af3-bc0d-1571dd4ee76dlorlatinib 25 MG Oral Tablet [PSN] · lorlatinib 25 MG Oral Tablet [SCD]212These highlights do not include all the information needed to use LORBRENA safely and effectively. See full prescribing information for LORBRENA. LORBRENA ® (lorlatinib) tablets, for oral use Initial U.S. Approval: 201820260209
004f93d7-a1cd-4b67-9207-31cdcb5c5976lorlatinib 25 MG Oral Tablet [PSN] · lorlatinib 25 MG Oral Tablet [SCD]23These highlights do not include all the information needed to use LORBRENA safely and effectively. See full prescribing information for LORBRENA. LORBRENA ® (lorlatinib) tablets, for oral use Initial U.S. Approval: 201820260213